Akston Biosciences Corporation
BioTech/Drugs - Beverly, MA, US
Akston Biosciences Corporation Employees
Akston Biosciences Corporation Senior Management
Akston Biosciences Corporation Details
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. Founded by the team that developed the world's first clinical glucose-responsive insulin at SmartCells, Inc., Akston's COVID-19 vaccine candidate is in Phase II trials in the Netherlands. It has partnered with Dechra Pharmaceuticals PLC to commercialize once-a-week canine and feline insulin therapies. The company employs 35 people, has over 3,500 ft2 of research laboratory space and a 12,400 ft2 GMP clean room biologics manufacturing facility.
Akston Biosciences Corporation Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
SSL Certificates
Media Temple SSL
Hosting
Amazon AWS
Other
Mobile Friendly